Prognostic and Immunotherapeutic Role of TACC3 in Pancancer and Its Impact on Proliferation and Docetaxel Resistance in Lung Adenocarcinoma
Our investigation of TACC3 revealed its potential as a promising target both for immunosuppression and docetaxel resistance in pancancer, especially in lung adenocarcinoma.
Authors
- Chenchang Xu
- Wenjuan Wang (ORCID: https://orcid.org/0000-0003-1873-8364)
- Xinyuan Ding (ORCID: https://orcid.org/0000-0002-8982-6807)
- Qian Liu (ORCID: https://orcid.org/0000-0002-6986-5542)
- Lei Chen (ORCID: https://orcid.org/0009-0003-4906-5163)
- Biao Liu (ORCID: https://orcid.org/0000-0001-6920-7016)
- Ying Zhu (ORCID: https://orcid.org/0000-0001-5484-7600)
- Jianyu Xu (ORCID: https://orcid.org/0000-0002-0870-7671)
- Jiantong Sun
Institutions
- Soochow University (CN)
- Suzhou Municipal Hospital (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Oncology
- Published
- 2024-11-07
- DOI
- https://doi.org/10.1159/000542450
- Citations
- 1
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.23